Skip to Main Content

Author Details

Irina Kalatskaya
EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA)
2003
23
15
PMIDPaper TitleJournal TitlePublished Year
37202447Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment.Sci Rep2023
30554450Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.Head Neck2019
35100692Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers.JCO Precis Oncol2019
31190949Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma.Clin Exp Gastroenterol2019
31059681Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma.Ann Thorac Surg2019
28659176ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.Genome Med2017
28728573Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA.BMC Mol Biol2017
26852132Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer.Breast Cancer Res2016
27415609Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma.Ann N Y Acad Sci2016
23086229Interruption of the ionic lock in the bradykinin B2 receptor results in constitutive internalization and turns several antagonists into strong agonists.J Pharmacol Exp Ther2013
23890051Pathprinting: An integrative approach to understand the functional basis of disease.Genome Med2013
22225778Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.Breast Cancer Res2012
22986220Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.Mol Cell Proteomics2012
22851698Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.Mol Cell Biol2012
22498892Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells.Ann Surg2012
21067998Reactome: a database of reactions, pathways and biological processes.Nucleic Acids Res2011
21593195Early G⿁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.Clin Cancer Res2011
19255243AMD3100 is a CXCR7 ligand with allosteric agonist properties.Mol Pharmacol2009
16740132C-terminal fusion of eGFP to the bradykinin B2 receptor strongly affects down-regulation but not receptor internalization or signaling.Biol Chem2006
15634338The role of helix 8 and of the cytosolic C-termini in the internalization and signal transduction of B(1) and B(2) bradykinin receptors.FEBS J2005
15161928Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor.J Biol Chem2004
12742821Expression levels strongly affect ligand-induced sequestration of B2 bradykinin receptors in transfected cells.Am J Physiol Heart Circ Physiol2003
12742822Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure.Am J Physiol Heart Circ Physiol2003
  • 1 - 23 of 23

Recommended Authors

Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Nottingham Trent University
Career Start Year 2010
Number of shared co-authors 0
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
University of Laval
Career Start Year 2007
Number of shared co-authors 2
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 0
Universite Cote d'Azur, CNRS UMR5
Career Start Year 2004
Number of shared co-authors 0
Hubei Engineering Research Center for Bio-enzyme Catalysis, Hubei University
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Merck & Co., Inc.
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 2
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Hospital for Sick Children
Career Start Year 1993
Number of shared co-authors 6
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
College of Medicine, University of Saskatchewan
Career Start Year 1992
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 1991
Number of shared co-authors 2
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 2
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 1

Collaborators

Ontario Institute for Cancer Research, University Avenue
Co-authored papers 13
University of California los angeles
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 3
University of Edinburgh
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Dalla Lana School of Public Health, University of Toronto
Co-authored papers 1
University of Melbourne
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Margaret Cancer Center
Co-authored papers 1
Co-authored papers 1
The Weizmann Institute of Science
Co-authored papers 1
Agriculture and Agri-Food Canada
Co-authored papers 1
Tom Baker Cancer Centre
Co-authored papers 1
University of California at Berkeley
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Harvard T.H. Chan School of Public Health
Co-authored papers 1
Princess Margaret Cancer Centre
Co-authored papers 1
NYU Grossman School of Medicine
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
University of Edinburgh
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Eastern Virginia Medical School
Co-authored papers 1
Eastern Virginia Medical School
Co-authored papers 1
Institute of Cancer Research
Co-authored papers 1
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Co-authored papers 1
Eastern Virginia Medical School
Co-authored papers 1
Oregon Health and Science University
Co-authored papers 1